Katie Mok1, Michael D Christian2, Sandra Nelson3, Lisa Burry4. 1. , BScPhm, ACPR, RPh, is with Mount Sinai Hospital, Toronto, Ontario. 2. , MD, MSc, FRCP, is with Mount Sinai Hospital, Toronto, Ontario. 3. , PharmD, RPh, is with Mount Sinai Hospital, Toronto, Ontario. 4. , BScPharm, PharmD, RPh, is with Mount Sinai Hospital, Toronto, Ontario.
Abstract
BACKGROUND: Current evidence suggests that administration of appropriate antibiotic therapy within 1 h after the onset of hypotension significantly improves mortality rates among patients with severe sepsis and septic shock. OBJECTIVES: To determine the interval from recognition of severe sepsis or septic shock in inpatients to initial administration of antibiotic and to assess institutional compliance with the Surviving Sepsis Campaign's recommendation for early antibiotic therapy. METHODS: A 6-month retrospective chart analysis was conducted to determine the interval from documented onset of hypotension to initial administration of antibiotic for patients with severe sepsis or septic shock. Patients who were admitted to a general medicine ward, a surgery ward, or the intensive care unit (ICU) of a 475-bed university-affiliated hospital and who met the criteria for severe sepsis or septic shock were eligible for inclusion. Patients who received antibiotics before meeting the criteria for severe sepsis or septic shock were excluded. RESULTS: Charts for 100 patients with severe sepsis or septic shock were reviewed. The mean age was 69.0 years (standard deviation 18.7 years), and 56% were men. The median interval from onset of severe sepsis or septic shock to administration of antibiotic was 4.00 h (interquartile range [IQR] 1.80-6.45 h). The median interval from the time a physician ordered an antibiotic to administration of the drug was 1.28 h (IQR 0.57-3.05 h). The interval between ordering and administration differed significantly for patients on the wards (5.67 h), those with onset in the ICU (4.00 h), and those with onset in the emergency department (3.28 h) (p = 0.039). The overall survival rate was 56%. CONCLUSION: At the study hospital, the interval from onset of severe sepsis or septic shock to initial administration of antibiotic to inpatients exceeded the 1-h period recommended by the Surviving Sepsis Campaign. These results will be used as a baseline for future quality assurance and improvement initiatives aimed at minimizing the time to antibiotic administration for this group of patients, who are at high risk of death.
BACKGROUND: Current evidence suggests that administration of appropriate antibiotic therapy within 1 h after the onset of hypotension significantly improves mortality rates among patients with severe sepsis and septic shock. OBJECTIVES: To determine the interval from recognition of severe sepsis or septic shock in inpatients to initial administration of antibiotic and to assess institutional compliance with the Surviving Sepsis Campaign's recommendation for early antibiotic therapy. METHODS: A 6-month retrospective chart analysis was conducted to determine the interval from documented onset of hypotension to initial administration of antibiotic for patients with severe sepsis or septic shock. Patients who were admitted to a general medicine ward, a surgery ward, or the intensive care unit (ICU) of a 475-bed university-affiliated hospital and who met the criteria for severe sepsis or septic shock were eligible for inclusion. Patients who received antibiotics before meeting the criteria for severe sepsis or septic shock were excluded. RESULTS: Charts for 100 patients with severe sepsis or septic shock were reviewed. The mean age was 69.0 years (standard deviation 18.7 years), and 56% were men. The median interval from onset of severe sepsis or septic shock to administration of antibiotic was 4.00 h (interquartile range [IQR] 1.80-6.45 h). The median interval from the time a physician ordered an antibiotic to administration of the drug was 1.28 h (IQR 0.57-3.05 h). The interval between ordering and administration differed significantly for patients on the wards (5.67 h), those with onset in the ICU (4.00 h), and those with onset in the emergency department (3.28 h) (p = 0.039). The overall survival rate was 56%. CONCLUSION: At the study hospital, the interval from onset of severe sepsis or septic shock to initial administration of antibiotic to inpatients exceeded the 1-h period recommended by the Surviving Sepsis Campaign. These results will be used as a baseline for future quality assurance and improvement initiatives aimed at minimizing the time to antibiotic administration for this group of patients, who are at high risk of death.
Entities:
Keywords:
antibiotics; septic shock; severe sepsis; timing
Authors: H Bryant Nguyen; Stephen W Corbett; Kevin Menes; Thomas Cho; Jennifer Daugharthy; Walter Klein; William A Wittlake Journal: Acad Emerg Med Date: 2005-12-19 Impact factor: 3.451
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598
Authors: A Gacouin; Y Le Tulzo; S Lavoue; C Camus; J Hoff; R Bassen; C Arvieux; C Heurtin; R Thomas Journal: Intensive Care Med Date: 2002-04-20 Impact factor: 17.440
Authors: David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Anis Davoudi; Duane B Corbett; Tezcan Ozrazgat-Baslanti; Azra Bihorac; Scott C Brakenridge; Todd M Manini; Parisa Rashidi Journal: IEEE EMBS Int Conf Biomed Health Inform Date: 2018-04-09
Authors: José Garnacho-Montero; Antonio Gutiérrez-Pizarraya; Ana Escoresca-Ortega; Esperanza Fernández-Delgado; José María López-Sánchez Journal: Crit Care Date: 2015-08-27 Impact factor: 9.097
Authors: Gigimol Stephen; Dane Moran; Joan Broderick; Hanan A Shaikh; Megan M Tschudy; Cheryl Connors; Tammy Williams; Julius C Pham Journal: Pediatr Qual Saf Date: 2017-04-17
Authors: Jolien Vandewalle; Sophie Steeland; Sara Van Ryckeghem; Melanie Eggermont; Elien Van Wonterghem; Roosmarijn E Vandenbroucke; Claude Libert Journal: Front Immunol Date: 2019-11-08 Impact factor: 7.561